Domain EYEION.com for sale! This premium domain is available now at Kadomain.com

Guselkumab demonstrates superior efficacy in clinical trials, offering new hope to Crohn's disease patients

  • medicalxpress.com language
  • 2025-07-18 05:30 event
  • 1 month ago schedule
Guselkumab demonstrates superior efficacy in clinical trials, offering new hope to Crohn's disease patients
In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that guselkumab, a medication with a mechanism of action that is new to inflammatory bowel disease (IBD) treatment, outperformed an established standard of care in promoting intestinal healing and symptom relief.

1.633. Novel enzyme therapy restores hearing in mice with rare genetic bone disorder

  • 1 month ago schedule
  • medicalxpress.com language

Scientists have successfully restored hearing in animal models of ENPP1 deficiency, a genetic disease in which individuals lack an enzyme essential for bone and blood vessel health. The rare disorder can cause hearing loss in as many as 75% of patients who live with it.

1.634. Why some men experience urinary leaks—or incontinence

  • 1 month ago schedule
  • medicalxpress.com language

There are three main types of urinary incontinence:

1.635. FDA plans to revoke 52 food standards

  • 1 month ago schedule
  • medicalxpress.com language

The U.S. Food and Drug Administration has announced a plan to revoke 52 food standards after concluding they are "obsolete and unnecessary."

1.636. Dietary intervention optimized using machine learning could lower risk of dementia

  • 1 month ago schedule
  • medicalxpress.com language

The term dementia is used to describe various debilitating neurological disorders characterized by a progressive loss of memory and a decline in mental abilities. Estimates suggest that over 55 million people worldwide are currently living with dementia, and this number could rise further over the next decades.

1.637. Surprising finding could pave way for universal cancer vaccine

  • 1 month ago schedule
  • medicalxpress.com language

An experimental mRNA vaccine has boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to "wake up" the immune system against cancer.

1.638. Less pain, more gain: Phenol-groups drive a new recipe for safer, stronger mRNA vaccines

  • 1 month ago schedule
  • medicalxpress.com language

As millions of people know firsthand, the most common side effect of mRNA vaccines like the COVID-19 shot is inflammation: soreness, redness and a day or two of malaise. But what if mRNA vaccines could be redesigned to sidestep that response altogether?

1.639. In rural Canadian town, new risk of measles deepens vaccine tensions

  • 1 month ago schedule
  • medicalxpress.com language

In the Canadian town of Aylmer, where Mennonites in traditional dress walk down the main street alongside secular locals, bitter divisions over vaccine skepticism that arose during COVID have intensified with the reemergence of measles.

1.640. Gene essential for vitamin D absorption could help unlock treatments for cancer and autoimmune diseases

  • 1 month ago schedule
  • medicalxpress.com language

Vitamin D is not only an essential nutrient, but also the precursor of the hormone calcitriol, indispensable for health. It regulates the uptake of phosphate and calcium necessary for bones by the intestines, as well as cell growth and the proper function of muscles, nerve cells, and the immune system.

1.641. Scar tissue in athletes' hearts tied to higher risk of dangerous cardiac rhythms

  • 1 month ago schedule
  • medicalxpress.com language

Scar tissue in the heart was associated with abnormal heart rhythms among healthy, long-time male endurance athletes aged 50 or older, potentially increasing their risk of sudden cardiac death, according to a small study published in Circulation: Cardiovascular Imaging, an American Heart Association journal.

1.642. Guselkumab demonstrates superior efficacy in clinical trials, offering new hope to Crohn's disease patients

  • 1 month ago schedule
  • medicalxpress.com language

In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that guselkumab, a medication with a mechanism of action that is new to inflammatory bowel disease (IBD) treatment, outperformed an established standard of care in promoting intestinal healing and symptom relief.

1.643. Here's what to know about chronic venous insufficiency

  • 1 month ago schedule
  • medicalxpress.com language

Swollen legs led to President Donald Trump being diagnosed with what's called chronic venous insufficiency. It's a fairly common condition among older adults but requires a thorough checkup to rule out more serious causes of swelling in the legs. Here are some things to know.

1.644. Surgeon-anesthesiologist teams with prior experience working together linked to fewer patient complications

  • 1 month ago schedule
  • medicalxpress.com language

The odds of patient complications following high-risk surgeries are lower when the surgeon and anesthesiologist have prior experience working together, according to a new study by researchers at ICES, Sunnybrook Research Institute and the University of Toronto.

1.645. Quebec's hereditary cancer gene linked to one ancestor

  • 1 month ago schedule
  • medicalxpress.com language

Researchers have shed new light on the most common genetic variant linked to hereditary cancer in Quebec's French-Canadian population. Their findings could result in cheaper and more effective screening methods.

1.646. Weight loss drugs like Ozempic may help prevent stroke and reduce brain injury-related complications, studies show

  • 1 month ago schedule
  • medicalxpress.com language

Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether using GLP-1 inhibitors could lessen the impact of stroke and related brain injuries or reduce the risk of stroke altogether. These medications, which lower blood sugar and often cause weight loss, are commonly prescribed for type 2 diabetes and obesity and include drugs like semaglutide (Ozempic).

1.647. Long-term obesity linked to expression of aging biomarkers

  • 1 month ago schedule
  • medicalxpress.com language

Long-term obesity is associated with the expression of biomarkers denoting antagonistic and integrative aging hallmarks in adults aged 28 to 31 years, according to a study published online July 11 in JAMA Network Open.

1.648. A potential therapeutic strategy could help prevent complications from sickle cell disease

  • 1 month ago schedule
  • medicalxpress.com language

Sickle cell disease can lead to a severe complication known as acute chest syndrome (ACS), but the underlying mechanisms are not well understood.

1.649. Delays in hypertension diagnosis linked to delays in medication prescribing

  • 1 month ago schedule
  • medicalxpress.com language

Delays in diagnosis of hypertension are common and associated with delays in treatment initiation, according to a study published online July 14 in JAMA Network Open.

1.650. AI and advanced data metrics are forging a new era in cancer research

  • 1 month ago schedule
  • medicalxpress.com language

A new project by a team of researchers across the nation analyzes the ways in which digitized health data, artificial intelligence models and other recent technological advancements have changed how cancers are diagnosed, studied and treated.

1.651. Q&A: Researcher discusses the unexpected role of protein aggregates in brain disease

  • 1 month ago schedule
  • medicalxpress.com language

Raghu R. Chivukula, MD, Ph.D., a physician-investigator in the Departments of Medicine & Surgery and the Center for Genomic Medicine at Massachusetts General Hospital and Harvard Medical School, is the senior author of a paper published in Science, titled "Polyglycine-mediated aggregation of FAM98B disrupts tRNA processing in GGC repeat disorders."

Cookie Policy

We use cookies and similar technologies to help the site provide a better user experience. By using the website you agree to our Cookie Policy, Terms of Use and Privacy Policy.